These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Evaluation of ofloxacin in the treatment of mucopurulent cervicitis: response of chlamydia-positive and chlamydia-negative forms. Chandeying V, Sutthijumroon S, Tungphaisal S. J Med Assoc Thai; 1989 Jun; 72(6):331-7. PubMed ID: 2778422 [Abstract] [Full Text] [Related]
48. Etiology of cervical inflammation. Paavonen J, Critchlow CW, DeRouen T, Stevens CE, Kiviat N, Brunham RC, Stamm WE, Kuo CC, Hyde KE, Corey L. Am J Obstet Gynecol; 1986 Mar; 154(3):556-64. PubMed ID: 3485379 [Abstract] [Full Text] [Related]
49. Prevalence of urogenital Chlamydia trachomatis infection in El Salvador. II. Gynaecology outpatients. Cañas Posada AB, Jonasson J, de Linares L, Bygdeman S. Int J STD AIDS; 1992 Mar; 3(6):434-6. PubMed ID: 1286120 [Abstract] [Full Text] [Related]
50. Screening for Chlamydia trachomatis and Neisseria gonorrhoeae in pregnant Turkish women. Genç M, Agaçfidan A, Yegenoglu Y, Turan O, Kuru U, Mårdh PA. Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):395-6. PubMed ID: 8354310 [No Abstract] [Full Text] [Related]
53. Underrecognition of cervical Neisseria gonorrhoeae and Chlamydia trachomatis infections in pregnant patients in the ED. Krivochenitser R, Jones JS, Whalen D, Gardiner C. Am J Emerg Med; 2013 Apr; 31(4):661-3. PubMed ID: 23391639 [Abstract] [Full Text] [Related]
54. Lack of utility of risk score and gynecological examination for screening for sexually transmitted infections in sexually active adolescents. Guimarães EM, Guimarães MD, Vieira MA, Bontempo NM, Seixas MS, Garcia MS, Daud LE, Côrtes RL, Alves Mde F. BMC Med; 2009 Mar 11; 7():8. PubMed ID: 19284575 [Abstract] [Full Text] [Related]
55. Diagnosis of mucopurulent cervicitis among women at risk for Chlamydia trachomatis infection. Katz BP, Caine VA, Jones RB. Sex Transm Dis; 1989 Mar 11; 16(2):103-6. PubMed ID: 2472673 [Abstract] [Full Text] [Related]
56. [Prevalence of Chlamydia trachomatis infections as a cause of sexually transmissible diseases--studies from a Berlin counseling center for venereal diseases]. Mäter-Böhm H, Hörnle R. Offentl Gesundheitswes; 1991 Oct 11; 53(10):693-7. PubMed ID: 1837603 [Abstract] [Full Text] [Related]
57. Screening for cervical Chlamydia trachomatis infections in two Dutch populations. Thewessen EA, van der Meijden WI, Doppenberg HJ, Mulder PG, Wagenvoort JH, Stolz E, Michel MF. Genitourin Med; 1990 Oct 11; 66(5):361-6. PubMed ID: 2245984 [Abstract] [Full Text] [Related]
58. Prevalence of infection with Neisseria gonorrhoeae or Chlamydia trachomatis in acute mucopurulent cervicitis. Ujević B, Habek JC, Habek D. Arh Hig Rada Toksikol; 2009 Jun 11; 60(2):197-203. PubMed ID: 19581214 [Abstract] [Full Text] [Related]
59. Cervicitis aetiology and case definition: a study in Australian women attending sexually transmitted infection clinics. Lusk MJ, Garden FL, Rawlinson WD, Naing ZW, Cumming RG, Konecny P. Sex Transm Infect; 2016 May 11; 92(3):175-81. PubMed ID: 26586777 [Abstract] [Full Text] [Related]
60. Laboratory-confirmed gonorrhea and/or chlamydia rates in clinically diagnosed pelvic inflammatory disease and cervicitis. Burnett AM, Anderson CP, Zwank MD. Am J Emerg Med; 2012 Sep 11; 30(7):1114-7. PubMed ID: 22030186 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]